Adhesion of renal carcinoma cells to endothelial cells depends on PKCμ

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Brenner, Walburgis ^a   Beitz, Silke ^a   Schneider, Elke ^a   Benzing, Frank ^a   Unger, Ronald E ^a   Roos, Frederik C ^a   Thüroff, Joachim W ^a   Hampel, Christian ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BETA1 INTEGRIN; BETA2 INTEGRIN; BETA3 INTEGRIN; BROXURIDINE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; PROTEIN KINASE C MU; PROTEIN SUBUNIT; ROTTLERIN; BETA INTEGRIN; PROTEIN KINASE C; PROTEIN KINASE D; PROTEIN KINASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; KIDNEY CARCINOMA; MONOLAYER CULTURE; WESTERN BLOTTING; BIOSYNTHESIS; CELL GROWTH; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; KIDNEY TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA, RENAL CELL; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; ENDOTHELIAL CELLS; HUMANS; INTEGRIN BETA CHAINS; KIDNEY NEOPLASMS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS;

EID: 77951811940     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-183     Document Type: Article

References (62)

1. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336. 10.1016/0092-8674(91)90642-C, 1703045.
2. Zernecke A, Weber KS, Erwig LP, Kluth DC, Schröppel B, Rees AJ, Weber C. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis. J Immunol 2001, 166:5755-5762.
3. Tanaka Y, Albelda SM, Horgan KJ, van Seventer GA, Shimizu Y, Newman W, Hallam J, Newman PJ, Buck CA, Shaw S. CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med 1992, 176:245-253. 10.1084/jem.176.1.245, 2119293, 1377224.
4. McIntyre TM, Prescott SM, Weyrich AS, Zimmerman GA. Cell-cell interactions: leukocyte-endothelial interactions. Curr Opin Hematol 2003, 10:150-158. 10.1097/00062752-200303000-00009, 12579042.
5. Greenwood J, Wang Y, Calder VL. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. Immunology 1995, 86:408-415. 1383944, 8550078.
6. DiVietro JA, Brown DC, Sklar LA, Larson RS, Lawrence MB. Immobilized stromal cell-derived factor-1alpha triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion. J Immunol 2007, 178:3903-3911.
7. Mattila P, Majuri ML, Renkonen R. VLA-4 integrin on sarcoma cell lines recognizes endothelial VCAM-1. Differential regulation of the VLA-4 avidity on various sarcoma cell lines. Int J Cancer 1992, 52:918-923. 10.1002/ijc.2910520615, 1281143.
8. Taichman DB, Cybulsky MI, Djaffar I, Longenecker BM, Teixidó J, Rice GE, Aruffo A, Bevilacqua MP. Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regul 1991, 2:347-355. 361800, 1716464.
9. Ruiz P, Dunon D, Sonnenberg A, Imhof BA. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins. Cell Adhes Commun 1993, 1:67-81. 10.3109/15419069309095682, 8081871.
10. Hangan D, Morris VL, Boeters L, von Ballestrem C, Uniyal S, Chan BM. An epitope on VLA-6 (alpha6beta1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver. Cancer Res 1997, 57:3812-3817.
11. Voura EB, Ramjeesingh RA, Montgomery AM, Siu CH. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell 2001, 12:2699-2710. 59705, 11553709.
12. Steinbach F, Tanabe K, Alexander J, Edinger M, Tubbs R, Brenner W, Stöckle M, Novick AC, Klein EA. The influence of cytokines on the adhesion of renal cancer cells to endothelium. J Urol 1996, 155:743-748. 10.1016/S0022-5347(01)66513-3, 8558717.
13. Tomita Y, Saito T, Saito K, Oite T, Shimizu F, Sato S. Possible significance of VLA-4 (alpha 4 beta 1) for hematogenous metastasis of renal-cell cancer. Int J Cancer 1995, 60:753-758. 10.1002/ijc.2910600604, 7896440.
14. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu-Rev Cell Dev Biol 1995, 11:549-599. 10.1146/annurev.cb.11.110195.003001, 8689569.
15. Kolanus W, Seed B. Integrins and inside-out signal transduction: converging signals from PKC and PIP3. Curr Opin Cell Biol 1997, 9:725-731. 10.1016/S0955-0674(97)80127-5, 9330877.
16. Bouvard D, Molla A, Block MR. Calcium/calmodulin-dependent protein kinase II controls alpha5beta1 integrin-mediated inside-out signalling. J Cell Sci 1998, 111:657-665.
17. Huang CF, Fan JH, Chuang NN. Farnesyl pyrophosphate promotes and is essential for the binding of RACK1 With beta-tubulin. J Exp Zool 2003, 298A:119-127.
18. Rosfjord EC, Maemura M, Johnson MD, Torri JA, Akiyama SK, Woods VL, Dickson RB. Activation of protein kinase C by phorbol esters modulates alpha2beta1 integrin on MCF-7 breast cancer cells. Exp Cell Res 1999, 248:260-271. 10.1006/excr.1998.4390, 10094832.
19. Brenner W, Benzing F, Gudejko-Thiel J, Fischer R, Färber G, Hengstler JG, Seliger B, Thüroff JW. Regulation of β1 integrin expression by PKCε in renal cancer cells. Int J Oncol 2004, 25:1157-1163.
20. Chun JS, Ha MJ, Jacobson BS. Differential translocation of protein kinase C epsilon during HeLa cell adhesion to a gelatin substratum. J Biol Chem 1996, 271:13008-13012. 10.1074/jbc.271.22.13008, 8662811.
21. Azzi A, Boscoboinik D, Hensey C. The protein kinase C family. Eur J Biochem 1992, 208:547-557. 10.1111/j.1432-1033.1992.tb17219.x, 1396661.
22. Valverde AM, Sinnett Smith J, Van Lint J, Rozengurt E. Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc Natl Acad Sci USA 1994, 91:8572-8576. 10.1073/pnas.91.18.8572, 44648, 8078925.
23. Hanks SK. Genomic analysis of the eukaryotic protein kinase superfamily: a perspective. Genome Biol 2003, 4:111.1-111.7.
24. Rozengurt E, Rey O, Waldron RT. Protein kinase D signaling. J Biol Chem 2005, 280:13205-13208. 10.1074/jbc.R500002200, 15701647.
25. Jaken S. Protein kinase C isozymes and substrates. Curr Opin Cell Biol 1996, 8:168-173. 10.1016/S0955-0674(96)80062-7, 8791416.
26. Blobe GC, Obeid LM, Hannun YA. Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev 1994, 13:411-431. 10.1007/BF00666107, 7712599.
27. Brenner W, Färber G, Herget T, Wiesner C, Hengstler JG, Thüroff JW. Protein Kinase C eta is associated with progression of renal cell carcinoma (RCC): a systematic study of eleven PKC-isoforms in RCC in relation to histopathological parameters. Anticancer Res 2003, 23:4001-4004.
28. Manni A, Buckwalter E, Etindi R, Kunselman S, Rossini A, Mauger D, Dabbs D, Demers L. Induction of a less aggressive breast cancer phenotype by protein kinase C-alpha and -beta overexpression. Cell Growth Differ 1996, 7:1187-1198.
29. Borner C, Ueffing M, Jaken S, Parker PJ, Weinstein IB. Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of rat fibroblasts. Possible molecular mechanisms. J Biol Chem 1995, 270:78-86. 10.1074/jbc.270.1.78, 7814423.
30. Hashimura T, Tubbs RR, Connelly R, Caufield MJ, Trindade CS, McMahon JT, Galetti TP, Edinger M, Sandberg AA, Dal Cin P, Sait SJ, Pontes JE. Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma. Cancer Res 1989, 49:7064-7071.
31. Brenner W, Hempel G, Steinbach F, Hohenfellner R, Thüroff JW. Enhanced expression of ELAM-1 on endothelium of renal cell carcinoma compared to the corresponding normal renal tissue. Cancer Lett 1999, 143:14-21.
32. Unger RE, Krump-Konvalinkova V, Peters K, Kirkpatrick CJ. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res 2002, 64:384-397. 10.1006/mvre.2002.2434, 12453433.
33. Brenner W, Färber G, Herget T, Lehr HA, Hengstler JG, Thüroff JW. Loss of the tumor suppressor protein PTEN during renal carcinogenesis. Int J Cancer 2002, 99:53-57. 10.1002/ijc.10303, 11948491.
34. Miles FL, Pruitt FL, van Golen KL, Cooper CR. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 2008, 25:305-324. 10.1007/s10585-007-9098-2, 17906932.
35. Goekjian PG, Jirousek MR. Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development. Curr Med Chem 1999, 6:877-903.
36. Brenner W, Greber I, Gudejko-Thiel J, Beitz S, Schneider E, Walenta S, Peters K, Unger R, Thüroff JW. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase. Int J Oncol 2008, 32:1125-1131.
37. Chen J, Deng F, Singh SV, Wang QJ. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res 2008, 68:3844-3853. 10.1158/0008-5472.CAN-07-5156, 18483269.
38. Van Lint J, Rykx A, Vantus T, Vandenheede JR. Molecules in focus: Getting to know protein kinase D. Int J Biochem Cell Biol 2002, 34:577-581. 10.1016/S1357-2725(01)00163-7, 11943587.
39. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999, 18:4440-4449. 10.1038/sj.onc.1202827, 10442635.
40. De Kimpe L, Janssens K, Derua R, Armacki M, Goicoechea S, Otey C, Waelkens E, Vandoninck S, Vandenheede JR, Seufferlein T, Van Lint J. Characterization of cortactin as an in vivo protein kinase D substrate: interdependence of sites and potentiation by Src. Cell Signal 2009, 21:253-263. 10.1016/j.cellsig.2008.10.015, 19038333.
41. Eiseler T, Döppler H, Yan IK, Goodison S, Storz P. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res 2009, 11:R13. 10.1186/bcr2232, 2687718, 19243594.
42. Syed V, Mak P, Du C, Balaji KC. β-Catenin mediates alteration in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E-cadherin and protein kinase D1. J Cell Biochem 2008, 104:82-95. 10.1002/jcb.21603, 17979146.
43. Du C, Jaggi M, Zhang C, Balaji KC. Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin. Cancer Res 2009, 69:1117-1124. 10.1158/0008-5472.CAN-07-6270, 19141652.
44. Woods AJ, White DP, Caswell PT, Norman JC. PKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. EMBO J 2004, 23:2531-2543. 10.1038/sj.emboj.7600267, 449777, 15192707.
45. Higai K, Miyazaki N, Azuma Y, Matsumoto K. Interleukin-1beta induces sialyl Lewis × on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS Lett 2006, 580:6069-6075. 10.1016/j.febslet.2006.09.073, 17054948.
46. Cowell CF, Yan IK, Eiseler T, Leightner AC, Döppler H, Storz P. Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1. J Cell Biochem 2009, 106:714-728. 10.1002/jcb.22067, 19173301.
47. Steinbach F, Tanabe K, Alexander J, Edinger M, Tubbs R, Brenner W, Stöckle M, Novick AC, Klein EA. The influence of cytokines on the adhesion of renal cancer cells to endothelium. J Urol 1996, 155:743-748. 10.1016/S0022-5347(01)66513-3, 8558717.
48. Ivaska J, Whelan RD, Watson R, Parker PJ. PKC epsilon controls the traffic of beta1 integrins in motile cells. EMBO J 2002, 21:3608-3619. 10.1093/emboj/cdf371, 126116, 12110574.
49. Palmantier R, George MD, Akiyama SK, Wolber FM, Olden K, Roberts JD. Cis-polyunsaturated fatty acids stimulate beta1 integrin-mediated adhesion of human breast carcinoma cells to type IV collagen by activating protein kinases C-epsilon and -mu. Cancer Res 2001, 61:2445-2452.
50. Engers R, Mrzyk S, Springer E, Fabbro D, Weissgerber G, Gernharz CD, Gabbert HE. Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression. Br J Cancer 2000, 82:1063-1069. 10.1054/bjoc.1999.1043, 2374431, 10737390.
51. Petiti JP, De Paul AL, Gutiérrez S, Palmeri CM, Mukdsi JH, Torres AI. Activation of PKC epsilon induces lactotroph proliferation through ERK1/2 in response to phorbol ester. Mol Cell Endocrinol 2008, 289:77-84. 10.1016/j.mce.2008.04.015, 18534741.
52. Sinnett-Smith J, Zhukova E, Hsieh N, Jiang X, Rozengurt E. Protein kinase D potentiates DNA synthesis induced by Gq-coupled receptors by increasing the duration of ERK signaling in swiss 3T3 cells. J Biol Chem 2004, 279:16883-16893. 10.1074/jbc.M313225200, 14963034.
53. Brändlin I, Hübner S, Eiseler T, Martinez-Moya M, Horschinek A, Hausser A, Link G, Rupp S, Storz P, Pfizenmaier K, Johannes FJ. Protein kinase C (PKC)eta-mediated PKC mu activation modulates ERK and JNK signal pathways. J Biol Chem 2002, 277:6490-6496. 10.1074/jbc.M106083200, 11741879.
54. Brenner W, Wiesner C, Färber G, Herget T, Hengstler JG, Thüroff JW. Gender specific expression of tumor suppressor PKCδ versus oncogenic PKCη in renal cell carcinoma. EXCLI Journal 2003, 2:45-51.
55. Watanabe T, Ono Y, Taniyama Y, Hazama K, Igarashi K, Ogita K, Kikkawa U, Nishizuka Y. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc Natl Acad Sci USA 1992, 89:10159-10163. 10.1073/pnas.89.21.10159, 50297, 1438205.
56. Ashton AW, Watanabe G, Albanese C, Harrington EO, Ware JA, Pestell RG. Protein kinase Cdelta inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27(Kip1). J Biol Chem 1999, 274:20805-20811. 10.1074/jbc.274.30.20805, 10409620.
57. Fukumoto S, Nishizawa Y, Hosoi M, Koyama H, Yamakawa K, Ohno S, Morii H. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J Biol Chem 1997, 272:13816-13822. 10.1074/jbc.272.21.13816, 9153238.
58. Bharti A, Kraeft SK, Gounder M, Pandey P, Jin S, Yuan ZM, Lees-Miller SP, Weichselbaum R, Weaver D, Chen LB, Kufe D, Kharbanda S. Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol Cell Biol 1998, 18:6719-6728. 109255, 9774685.
59. Saharinen P, Ekman N, Sarvas K, Parker P, Alitalo K, Silvennoinen O. The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. Blood 1997, 90:4341-4353.
60. Ringshausen I, Schneller F, Bogner C, Hipp S, Duyster J, Peschel C, Decker T. Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta. Blood 2002, 100:3741-3748. 10.1182/blood-2002-02-0539, 12393602.
61. Jane EP, Premkumar DR, Pollack IF. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells. J Pharmacol Exp Ther 2006, 319:1070-1080. 10.1124/jpet.106.108621, 16959960.
62. Gschwendt M, Müller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 1994, 199:93-98. 10.1006/bbrc.1994.1199, 8123051.